Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | HLA-A2 restricted synthetic peptide vaccine |
| Trade Name | |
| Synonyms | HLA-A2 restricted synthetic tumor antigen |
| Drug Descriptions |
HLA-A2 restricted synthetic peptide vaccine is a cancer vaccine comprised of synthetic peptides for tumor associated antigens, which may induce increased anti-tumor immune response (PMID: 23955319). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| HLA-A2 restricted synthetic peptide vaccine | HLA-A2 restricted synthetic peptide vaccine | 0 | 0 |
| HLA-A2 restricted synthetic peptide vaccine + Imiquimod | HLA-A2 restricted synthetic peptide vaccine Imiquimod | 0 | 1 |